| Pharmaceutical Information |
| Drug Name |
Ciclesonide |
| Drug ID |
BADD_D00460 |
| Description |
Ciclesonide is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco. |
| Indications and Usage |
For the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older. |
| Marketing Status |
Prescription |
| ATC Code |
R01AD13; R03BA08 |
| DrugBank ID |
DB01410
|
| KEGG ID |
D01703
|
| MeSH ID |
C120481
|
| PubChem ID |
6918155
|
| TTD Drug ID |
D0K7HU
|
| NDC Product Code |
70515-701; 64918-1900; 53104-7633; 70515-712; 24002-0016; 70515-711; 70515-737; 64918-1112 |
| Synonyms |
ciclesonide | (R)-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate | Alvesco | Omnaris |
|
| Chemical Information |
| Molecular Formula |
C32H44O7 |
| CAS Registry Number |
126544-47-6 |
| SMILES |
CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
